Trial intelligence / Profile preview

Liraglutide in T2D with Severe Renal Insufficiency

NCT01394341Phase 4Completed

Start
Sep 2011
Primary completion
Oct 2013
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM). Started Sep 2011; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01394341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01394341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call